XTX Topco Ltd

Position in BHVN — Biohaven Ltd.

CIK 1828301 LONDON, X0

Position in BHVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,532,025

-$923,732 QoQ

Shares Held

170,163

-58.3% QoQ

Ownership

0.113%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#81

of 294 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $413,155,276 across 381 Biotechnology names. BHVN ranks #48 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,532,025	170,163	-58.3%	Shares	Defined	2026-08-14
2026-03-31	$3,455,757	408,482	+389.5%	Shares	Defined	2026-05-15
2025-12-31	$942,206	83,455	+31.1%	Shares	Defined	2026-02-17
2025-09-30	$955,221	63,639	+69.9%	Shares	Defined	2025-11-14
2025-03-31	$900,201	37,446	+15.2%	Shares	Defined	2025-05-08
2024-09-30	$1,624,524	32,510	+278.5%	Shares	Defined	2024-11-14
2024-06-30	$298,124	8,589	+0.6%	Shares	Defined	2024-08-12
2024-03-31	$467,107	8,541	-34.3%	Shares	Defined	2024-05-13
2023-09-30	$338,051	12,997	-11.4%	Shares	Defined	2023-11-13
2023-06-30	$350,954	14,672	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.